Popular Science Writing Requires Inspiration, Perspiration

The unexpected--and unprecedented--success of theoretical physicist Stephen Hawking's A Brief History of Time: From the Big Bang to Black Holes created a big bang of its own in the world of publishing. The Cambridge University re- searcher's textual flight through space and time, published by New York's Bantam Books in April 1988, earned rave reviews the world over and spent 100 weeks on the New York Times bestseller list, ringing up sales of some 1 million copies in its hardcover edition alone

Written byA. J. S. Rayl
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Publishers did double-takes, then scrambled to sign up scientists with stories to tell and theories to explain. As a result, popular science books--those that bring scientific knowledge to the public in a voice that the layman can understand and appreciate--have become something of a trend, and more scientists than ever before are venturing into the world of mass-market publishing.

Indicators are that the genre will continue to expand for some time--just what one would expect following a big bang. Strengthening the anticipated demand for popular science books is the speculation that the public's fascination with science is on the rise, spurred on in part, no doubt, by Hollywood's blockbuster science-fiction movies and hopes for cures for catastrophic diseases like AIDS and cancer. "We're always on the lookout for science books," says Leslie Meredith, executive editor at Bantam.

There are two stages to book publishing--writing, editing, and printing the manuscript serve ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies